Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells. - Jones D; Whitehead CA; Dinevska M; Widodo SS; Furst LM; Morokoff AP; Kaye AH; Drummond KJ; Mantamadiotis T; Stylli SS (Molecular and cellular biochemistry, 2023)